A mere 4% of pharma’s digital product launches proved successful. And to change that, the industry needs to be bolder and more customer-centric. That’s according to a new report out by Graphite and Reuters Events, which found that pharma’s “naturally risk-averse culture” is holding back its digital launches.
Mergers and acquisitions in digital health on the rise again
A new report by Rock Health describes mergers and acquisitions as a new way to invest in digital health. It takes place despite a significant